A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE)

Anna Liza M.P. de Leeuw*, Jordi Giralt, Yungan Tao, Sergi Benavente, Thanh Vân France Nguyen, Frank J.P. Hoebers, Ann Hoeben, Chris H.J. Terhaard, Lip Wai Lee, Signe Friesland, Roel J.H.M. Steenbakkers, Lisa Tans, Jolien Heukelom, Mutamba T. Kayembe, Simon R. van Kranen, Harry Bartelink, Coen R.N. Rasch, Jan Jakob Sonke, Olga Hamming-Vrieze*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE)'. Together they form a unique fingerprint.

Medicine and Dentistry